strong sens investor bit hesit given
approach septemb investor day point compani plan
lay result strateg review new ceo dirk van de put
reason expect focu like shift margin stori
better balanc top-lin growth margin view mani investor
less will buy share margin progress slow even
temporarili top line acceler becom visibl
opinion ep result come play quarter
could help investor becom comfort gross margin progress fuel
invest spend relat improv organ top line growth justifi
increment spend quarter would view specif underli
organ growth yoy gross margin expand yoy vs
yoy forecast consensu yoy continu expect higher yoy
gross margin year provid investor bit confid
fund mechan increas invest without need
rebas margin structur still concern among view
separ would note ytd snack global categori growth yoy
acceler yoy even though underli organ
growth yoy lag end market consumpt north america
improv track could see gap narrow move forward
categori growth market share trend improv akin mdlz
messag septemb better balanc sale margin easier
swallow view
underli organ growth yoy mdlz favor
organ growth outlook high end origin yoy rang
wed expect investor begin get comfort pend strateg
review would expect stock multipl begin better reflect
quarterli annual ep usd
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
overweight continu recommend
share given long-term potenti compani
deliv peer-lead sale earn growth
compani strateg option rel
valuat believ upsid
assum robust top-lin earn growth
along benefit fx see upsid
ep potenti appli price-to-earnings
multipl impli upsid valu
assum challeng organ sale backdrop
less favor fx less meaning margin
expans see potenti downsid
ep estim appli price-to-earnings multipl
impli downsid valu
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
stock
see organ sale growth toward upper end yoy
rang exclud malwar benefit organ sale closer yoy
though compani face tougher top-lin comp believ improv categori
growth better share trend augur well least yoy organ sale growth
result forecast yoy said given mdlz expect benefit
ep fx vs benefit previous lower full year ep
estim previous alreadi took account oner
fx environ ahead full year ep estim
previous maintain price target base price-to-earnings
multipl updat ep estim premium peer
think justifi given mdlz acceler top-lin growth global gross
margin expans compar previou price target base
price-to-earnings multipl previou ep forecast
andrew lazar herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
author contribut research report research analyst unless otherwis indic
public date top report reflect local time report produc may differ releas date provid
gmt
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis barclay research depart
oper independ absa research depart absa research produc absa bank limit act corpor
invest bank divis part barclay africa group limit affili invest bank barclay bank plc elig
client may receiv research report research depart may reach differ conclus may contain differ
conflict forecast recommend trade idea
price sourc thomson reuter last avail close price relev trade market unless anoth time sourc
